| Sep 12, 2024 |
Sep 16, 2024 |
Pelthos Therapeutics Inc.
|
Director |
Buy |
90.0
|
+10,400
|
12.81%
|
✗
|
$9.8K |
| Feb 10, 2022 |
Feb 14, 2022 |
COLLEGIUM PHARMACEUTICAL, INC
|
EVP and Chief Medical Officer |
Sell |
95.0
|
+36,706
|
39.23%
|
✗
|
$111.1K |
| Apr 1, 2021 |
Apr 5, 2021 |
COLLEGIUM PHARMACEUTICAL, INC
|
EVP and Chief Medical Officer |
Sell |
42.5
|
-3,119
|
-3.23%
|
✗
|
$72.9K |
| Feb 10, 2021 |
Feb 12, 2021 |
COLLEGIUM PHARMACEUTICAL, INC
|
EVP and Chief Medical Officer |
Sell |
42.5
|
-2,300
|
-2.32%
|
✗
|
$59.7K |
| Apr 1, 2020 |
Apr 3, 2020 |
COLLEGIUM PHARMACEUTICAL, INC
|
EVP and Chief Medical Officer |
Sell |
46.3
|
-2,920
|
-4.65%
|
✗
|
$45.2K |